Abstract
Breast cancer accounts for 20% of all cancer deaths among women in the United States. This disease is the third leading cause of cancer deaths today, affecting in their lifetime, 1 out of every 13 women. When carcinoma of the breast is diagnosed in a pregnant or lactating woman, it is particularly tragic. Breast cancer coinciding with pregnancy or lactation occurs about once in every 1000 pregnancies, and represents 1% of total breast cancers. If only women of childbearing age are considered, then the reported frequencies of coincidence range from 7 to 14% of breast cancers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
MacMahon, B., Cole, P., and Lin, T. M., 1970, Age at first birth and breast cancer risk, Bull. WHO 43: 209–221.
Juret, P., Couette, J. E., Mandard, A. M., Carré, A., Delozier, T., Burne, D., and Vernhes, J. C., 1976, Age at menarche as a prognostic factor in human breast cancer, Eur. J. Cancer 12 (9): 701–704.
Lilienfeld, A. M., Coombs, J., Bross, I. D. J., and Chamberlain, A., 1975, Marital and reproductive experience in a community-wide epidemiological study of breast cancer, Johns Hopkins Med. J. 136 (4): 157–162.
MacMahon, B., Cole, P., and Brown, J., 1973, Etiology of human breast cancer: A review, J. Natl. Cancer Inst. 50: 21–42.
Sherman, B. M. and Korenman, S. G., 1974, Inadequate corpus luteum function: A pathophysiological interpretation of human breast cancer epidemology, Cancer 33: 1306–1312.
Stavraky, K. and Emmons, S. J., 1974, Breast cancer in premenopausal and postmenopausal women, J. Natl. Cancer Inst. 53 (2): 647–654.
Leis, H. P., Jr. and Raciti, A., 1976, The search for women at high risk, in: Risk Factors in Breast Cancer ( B. A. Stoll, ed.), Heinemann Medical Books, London p. 207–225.
Thomas, D. P. and Lilfienfeld, A. M., 1976, Geographic, reproductive and sociobiological factors, in: Risk Factors in Breast Cancer ( B. A. Stoll, ed.), William Heinemann Medical Books, London p. 25–53.
Miller, A. B. and Bulbrook, R. D., 1980, The epidemiology and etiology of breast cancer, N. Engl. J. Med. 303 (2): 1246–1248.
DeWaard, F., 1969, The epidemiology of breast cancer: Review and prospects, Int. J. Cancer 4: 577–586.
Diekamp, V., Bitran, J., and Ferguson, D. J., 1976, Breast cancer in young women, J. Reprod. Med. 17: 255–276.
Tannenbaum, A. and Silverstone, H. 1957, Nutrition and the genesis of tumours, in: Cancer, Volume 1 ( R. W. Raven, ed.), Butterworths, London p. 306–334.
Vorherr, H. and Messer, R. H., 1978, Breast cancer: Potentially predisposing and protecting factors. Role of pregnancy, lactation and endocrine status, Am. J. Obstet. Gynecol. 130 (3): 335–358.
Hirayama, T. and Wynder, E. L., 1962, A study of the epidemiology of cancer of the breast: The influence of hysterectomy, Cancer 15: 28–38.
Dunn, J. E., Jr., 1969, Epidemiology and possible identification of the high risk group that could develop cancer of the breast, Cancer 23: 775–780.
Shapiro, S., Strax, P., Venet, L., and Fink, R., 1968, The search for risk factors in breast cancer, Am. J. Public Health 58: 820–835.
Cole, P., 1980, Major aspects of the epidemiology of breast cancer, Cancer (Suppl.) 46: 865–867.
Korenman, S. G., 1980, Estrogen window hypothesis of the etiology of breast cancer, Lancet 1: 700–701.
Lane-Claypon, J. E., 1926, A further Report on Cancer of the Breast with Special Reference to the Associated Antecedent Conditions. Ministry of Health Reports on Public Health and Medical Subjects, MO 32, His Majesty’s Stationery Office, London.
Wainwright, J. M., 1931, Comparison of conditions associated with breast cancer in Great Britain and America, Am. J. Cancer. 15: 2610.
Kamoi, M., 1960, Statistical study on relation between breast cancer and lactation period, 3. Study through relative liability, Tohoku J. Exp. Med. 72: 72–77.
Levin, M. L., Sheeke, P. R., Graham, S., and Glidewell, O., 1964, Lactation and menstrual function as related to cancer of the breast, Am. J. Public Health. 54: 580–587.
MacMahon, B., Lin, T. M., and Lowe, C. R., 1970, Lactation and cancer of the breast. A summary of an international study, Bull WHO. 42: 185–194.
Beatson, G. T., 1896, On the treatment of inoperable cases of carcinoma of the mamma: Suggestions for a new method of treatment with illustrative cases, Lancet 2: 104–162.
Huggins, C. and Bergenstal, D. M., 1952, Inhibition of human mammary and prostatic cancers by adrenalectomy, Cancer Res. 12: 134–141.
McGuire, W. L., Horwitz, K. B., and De la Garza, M., 1976, A biochemical basis for selecting endocrine therapy in human breast cancer, in: Breast Cancer: Trends in Research and Treatment ( J. C. Heuson, W. H. Mattheim, and M. Rozencweig, eds.), Raven Press, New York, pp. 127–182.
Pearson, O. H. and Ray, B. S., 1960, Hypophysectomy in the treatment of metastatic mammary cancer, Am. J. Surg. 99: 544–552.
Jensen, E. V., Smith, S., and DeSombre, E. R., 1976, Hormone dependency in breast cancer, J. Steroid Biochem. 7: 911–917.
Minton, J. P. and Dickey, R. P., 1973, Levodopa test to predict response of carcinoma of the breast to surgical ablation of endocrine glands, Surg. Gynecol. Obstet. 136: 971–974.
McGuire, W. L. (ed.), 1978, Hormones, Receptors and Breast Cancer, Raven Press, New York.
Santen, R. J., Worgul, T. J., Samojlik, E., Interrante, A., Boucher, N. E., White, D. S., Smart, E., Cox, C., and Wells, S. A., 1981, A randomized trial comparing surgical adrenalectomy with aminoglutethimide plus hydrocortisone in women with advanced breast cancer, N. Engl. J. Med. 305 (10): 545–551.
Bloom, N. D., Tobin, E. H., Schreibman, B., and Degenshein, G. A., 1980, The role of progesterone receptors in the management of advanced breast cancer, Cancer 45 (12): 2992–2997.
McGuire, W. L., 1978, Hormone receptors: Their role in predicting prognosis and response to endocrine therapy, Semin. Oncol. 5 (4): 428–433.
Brooks, S. C., Saunders, D. E., Singhakowinta, A., and Vaitkevicius, V. K., 1980, Relation of tumor content of estrogen and progesterone receptors with response of patient to endocrine therapy, Cancer 46: 2775–2778.
Dao, T. L. and Nemoto, T., 1980, Steroid receptors and response to endocrine ablations in women with metastatic cancer of the breast, Cancer 46: 2779–2782.
Degenshein, G. A., Bloom, N., and Tobin, E., 1980, The value of progesterone receptor assays in the management of advanced breast cancer, Cancer 46: 2789–2793.
Manni, A., Arafah, B. V., and Pearson, O., 1980, Estrogen and progesterone receptors in the prediction of response of breast cancer to endocrine therapy, Cancer 46: 2838–2841.
Pertschuk, L. P., Tobin, E. H., Gaetjens, E., Carter, A. C., Degenshein, G. A., Bloom, N. D., and Brigati, D. J., 1980, Histochemical assay of estrogen and progesterone receptors in breast cancer: Correlation with biochemical assays and patients response to endocrine therapies, Cancer 46: 2896–2901.
Skinner, L. G., Barnes, D. M., and Ribeiro, G. G., 1980, The clinical value of multiple steroid receptor assays in breast cancer management, Cancer 46: 2939–2945.
Young, P. C. M., Ehrlich, C. E., and Einhorn, L. H., 1980, Relationship between steroid receptors and response to endocrine therapy and cytotoxic chemotherapy in metastatic breast cancer, Cancer 46: 2961–2963.
DeSombre, E. R., Kledzik, G., Marshall, S., and Meites, J., 1976, Estrogen and prolactin receptor concentration in rat mammary tumors and response to endocrine ablation, Cancer Res. 36: 354–358.
Allegra, J. C., Lippman, M. E., Thompson, E. B., Simon, R., Barlock, A., Green, L., Huff, K., Hoan My T. Do, and Aitken, S. C., 1979, Distribution, frequency and quantitative analyses of estrogen, progesterone, androgen and glucocorticoid receptors in human breast cancer, Cancer Res. 39: 1447–1454.
Horwitz, K. B., McGuire, W. L., Pearson, O. H., and Segaloff, A., 1975, Predicting response to endocrine therapy in human breast cancer: A hypothesis, Science 189: 726–727.
Freifeld, M. L., Feil, P. D., and Bardin, C. W., 1974, The in vivo regulation of the progesterone receptor in guinea pig uterus: Dependence on estrogen and progesterone, Steroids 23: 93–103.
Horwitz, K. B. and McGuire, W. L., 1975, Specific progesterone receptors in human breast cancer, Steroids 25: 497–505.
McGuire, W. L., 1980, An update on estrogen and progesterone receptors in prognosis for primary and advanced breast cancer, in: Hormones and Cancer ( S. Iacobelli, ed.), Raven Press, New York.
McCormick, G. M. and Moon, R. C., 1965, Effect of pregnancy and lactation on growth of mammary tumors induced by 7,12-Dimethylbenz (A) anthracene (DMBA), Br. J. Cancer 19: 160–166.
Huggins, C. and Yang, N. C., 1962, Induction and extinction of mammary cancer. A striking effect of hydrocarbons permits analysis of mechanisms of causes and cures of breast cancer, Science 137: 257–262.
Huggins, C., 1965, Two principles in endocrine therapy of cancers: Hormone deprival and hormone interference, Cancer Res. 25: 1163–1175.
McCormick, G. M. and Moon, R. C., 1973, Effect of increasing doses of estrogen and progesterone on mammary carcinogenesis in the rat, Eur. J. Cancer. 9: 483–486.
Witliff, J. L., Gardner, D. G., Battema, W. L., and Gilbert, P. J., 1972, Specific estrogen receptors in the neoplastic and lactating mammary gland of the rat, Biochem. Biophys. Res. Commun. 48: 119–125.
Speroff, L., 1981, The ovary, in: Endocrinology and Metabolism ( P. Felig, J. D. Baxter, A. E. Broaders, and L. A. Frohman, eds.), Mcgraw-Hill Book Co., New York, p. 688.
Meites, J., Cassell, E. E., and Clark, J. H., 1971, Estrogen inhibition of mammary tumor growth in rats: counteraction by prolactin, Proc. Soc. Exp. Biol. Med. 137: 1225–1227.
Shiu, R. P. C., 1979, Prolactin receptors in human breast cancer cells in long-term tissue culture, Cancer Res. 39: 4381–4386.
Wilson, R. G., Forrest, A. P. M., Boyns, A. R., and Griffiths, K., 1973, Studies on human prolactin, in: Human Prolactin, Proceedings of the International Symposium on Human Prolactin (J. L. Pastells, C.Robyn, and F.J. G. Ebling, eds. ), Brussels, pp. 11–23.
Boyns, A. R., Cole, E. N., Griffiths, K., Roberts, M. M., Buchan, R., Wilson, R. G., and Forrest, A. P. M., 1973, Plasma prolactin in breast cancer, Eur. J. Cancer 9: 99–102.
Dickey, R. P. and Minton, J. P., 1972, L-Dopa effect on prolactin, F.S.H. and L.H. in women with advanced breast cancer: A preliminary report, Am. J. Obstet. Gynecol. 114: 267–269.
Franks, S., Ralphs, D. N. L., Seagroatti, V., and Jacobs, H. S., 1974, Prolactin concentrations in patients with breast cancer, Br. Med. J. 4: 320–321.
Boston Collaborative Drug Surveillance Program, 1974, Reserpine and breast cancer, Lancet 2: 669–671.
Armstrong, B., Stevens, N., and Doll, R., 1974, Retrospective study of the association between use of ranwolfia derivatives and breast cancer in English women, Lancet 2: 672–675.
Heinomen, O. P., Shapiro, S., Tuominen, L., and Turunen, M. I., 1974, Reserpine use in relation to breast cancer, Lancet 2: 675–677.
Minton, J. P. and Dickey, R. P., 1972, Prolactin, FSH and LH in breast cancer: Effect of levodopa and oophorectomy, Lancet 1: 1069–1070.
L’Hermite, M., Robyn, C., Heuson, J. C., and Rozencweig, M., 1974, Letter: Breast cancer regression under estrogen therapy, Br. Med. J. 1: 390.
Wilson, R. G., Buchan, R., Roberts, M. M., Forrest, A. P. M., Boyns, A. R., Cole, E. N., and Griffith, K., 1974, Plasma prolactin and breast cancer, Cancer 33: 1325–1327.
Moore, D. H., Long, C. A., Vaidya, A. B., Sheffield, J. B., Dion, A. S., and Lasfargucs, E. Y., 1979, Mammary tumors viruses, Adv. Cancer Res. 29: 347–417.
Dalton, A. J., Heine, V. J., and Melnick, J. L., 1975, Symposium: Characterization of oncornaviruses and related viruses—A report, J. Natl. Cancer Inst. 55: 941–942.
Moore, D. H., Charney, J., Kramarsky, B., Lasfargues, E. Y., Sarkar, N. H., Brennan, M. J., Burrows, J. H., Sirsat, S. M., Paymaster, J. C., and Vaidya, A. B., 1971, Search for a human breast cancer virus, Nature (London) 229: 611–614.
Gerard, G. F., Loewenstein, P. M., Green, M., and Rottman, F., 1975, Detection of reverse transcriptase in human breast tumours with poly(Cm)-oligo (dG), Nature 256: 140–143.
Axel, R., Gulati, S. C., and Spiegelman, S., 1972, Particles containing RNA-instructed DNA polynurase and virus-related RNA in human breast cancers, Proc. Nat. Acad. Sci. USA 69: 3133–3137.
Axel, R., Schlom, J., and Spiegelman, S., 1972, Presence in human breast cancer of RNA humologous to mouse mammary tumor virus RNA, Nature (London) 235: 32–36.
Spiegelman, S., Axel, R., and Schlom, J., 1972, Virus related RNA in human and mouse mammary tumors, J. Natl. Cancer Inst. 48: 1205–1211.
Mesa-Tejada, R., Keydar, I., Ramanrayanan, M., Ohno, T., Fenoglio, C., and Spiegelman, S., 1978, Detection in human breast carcinomas of an antigen immunologically related to a group specific antigen of mouse mammary tumor virus, Proc. Nat. Acad. Sci. USA 75: 1529–1533.
Vaidya, A. B., Black, M. M., Dion, A. S., and Moore, D. H., 1974, Homology between human breast tumor RNA and mouse mammary tumor virus genome, Nature (London) 249: 565–567.
Keydar, I., Mesa-Tejada, R., Ramanarayanan, M., Ohno, T., Fenoglio, C., and Spiegelman, S., 1978, Detection of viral proteins in mouse mammary tumors by immunoperoxidase staining of paraffin sections, Proc. Nat. Acad. Sci. USA 75: 1524–1528.
Bowen, J. M., Dmochowski, L., Miller, M. F., Priori, E. S., Seman, G., Dodson, M. L., and Maruyama, K., 1976, Implications of humoral antibody in mice and humans to breast tumor and mouse mammary tumor virus-associated antigens, Cancer Res. 36: 759–764.
Hoshino, M. and Dmochowski, L., 1973, Electron microscope study of antigens in cells of mouse mammary tumor cell lines by peroxidase-labeled antibodies in sera of mammary tumor bearing mice and of patients with breast cancer, Cancer Res. 33: 2551–2561.
Miller, M. F., Dmochowski, L., and Bowen, J. M., 1977, Immunoelectron microscope studies of antibodies in mouse sera directed against mouse mammary tumor virus, Cancer Res. 37: 2086–2091.
Priori, E. S., Anderson, D. E., Williams, W. C., and Dmochowski; L., 1972, Immunological studies on human breast carcinoma and mouse mammary tumors, J. Natl. Cancer Inst. 48: 1131–1135.
Black, M. M., 1977, Immunogenicity and MµMTV-like antigenicity of human breast cancer tissues, in: Contemporary topics in immunology, ( M. G. Hanna Jr. and F. Rapp, eds.) Plenum Press, New York, p. 239–262.
Black, M. M., Moore, D. H., Shore, B., Zachrau, R. E., and Leis, H. P., Jr., 1974, Effect of murine milk samples and human breast tissues on human leukocyte migration indices, Cancer Res. 34: 1054–1060.
Black, M. M., Zachrau, R. E., Shore, B., Moore, D. H., and Leis, H. P., Jr., 1975, Prognostically favorable immunogens of human breast cancer tissue: Antigenic similarity to murine mammary tumor virus, Cancer 35: 121–128.
Black, M. M., Zachrau, R. E., Dion, A. S., Shore, B., Fine, D. L., Leis, H. P., Jr., and Williams, C. J., 1976, Biological considerations of tumor-specific and virus-associated antigens of human breast cancers, Cancer Res. 36: 4137–4142.
Black, M. M., Zachrau, R. E., and Shore, B., 1981, MµMTV-like characteristics of human breast carcinoma immunogens, in: Bibliothica Haematologia Vol. 43, ( J. Clemmenson and D. S. Yohn, eds.), 559–564, Karger Co., New York.
Black, M. M., Zachrau, R. E., Shore, B., 1976, Biological considerations of tumor-specific and virus associated antigens of human breast cancers, Cancer Res. 36 (2 pt 2): 769–774.
Zachrau, R. E., Black, M. M., Dion, A. S., Shore, B., Isac, M., Andrade, A. M., and Williams, C. J., 1976, Prognostically significant protein components of human breast cancer tissues, Cancer Res. 36: 3143–3146.
Sarkar, N. H. and Moore, D. H., 1972, Electron microscopy in mammary cancer research, J. Natl. Cancer Inst. 48: 1051–1058.
Sarkar, N. H. and Moore, D. H., 1972, On the possibility of a human breast cancer virus, Nature (London) 236: 103–106.
Schlom, J. and Spiegelman, S., 1971, Simultaneous detection of reverse transcriptase and high molecular weight RNA unique to oncogenic RNA virsus, Science 174: 840–843.
Dion, A. S., Vaidya, A. B., and Fout, G. S., 1974, Isolation and characterization of RNA-directed DNA polymerase from a B-type RNA tumor virus, J. Virol. 14: 40–46.
Schlom, J., Colcher, D., Spiegelman, S., Gillespie, S., and Gillespie, D., 1973, Quantitation of RNA tumor viruses and viruslike particles in human milk by hybridization to polyadenylic acid sequences, Science 179: 696–698.
Axel, R., Schlom, J., and Spiegelman, S., 1972, Evidence for translation of viral-specific RNA in cells of a mouse mammary carcinoma, PNAS (USA) 69: 535–538.
Fraumeni, J. F., Jr., and Miller, R. W., 1971, Breast cancer from breast-feeding, Lancet 2: 1196–1197.
Tokuhata, G. K., 1969, Morbidity and mortality among offspring of breast cancer mothers, Am. J. Epidemiol. 89: 139–153.
Anderson, D. E., 1975, Genetics and breast cancer, in: Early Breast Cancer: Detection and Treatment ( H. S. Gallager, ed.), John Wiley, New York, p. 41–49.
Juret, P., 1981, Reproductive factors and the natural history of breast cancers. Reviews on endocrine-related cancer, Cancer 9: 29–35.
Dole, R., Muir, C., and Waterhouse, J. (eds.), 1970, International Union Against Cancer (UICC), Cancer Incidence in Five Continents, Volume 2, Springer-Verlag, Berlin.
Mausner, J. S., Shimkin, M. B., Moss, N. H., and Rosemond, G. P., 1969, Cancer of the breast in Philadelphia hospitals, 1951–1964, Cancer 231: 260–274.
Applewhite, R. R., Smith, L. R., and DiVincenti, F., 1973, Carcinoma of the breast associated with pregnancy and lactation, Am. Surg. 39: 101–104.
Treves, N., and Holleb, A. I., 1958, A report of 549 cases of breast cancer in women 35 years of age or younger, Surg. Gynecol. Obstet. 107: 271–283.
Horsley, J. S., III, Alrich, E. M., and Wright, C. B., 1969, Carcinoma of the breast in women 35 years of age or younger, Annals Surg. 169: 839–843.
Cancer Statistics: 25 year cancer survey, 1975, American Cancer Society Professional Education Publication, Ca—A Cancer Journal for Clinicians 25:2.
Rosemond, G. P., and Mayer, W. P., 1971, Pregnancy and breast cancer, in: Breast Cancer—Early and Late, (M. D. Anderson Hospital) Year Book Medical, Chicago, pp. 227–235.
Rosemond, G. P., 1964, Management of patients with carcinoma of the breast in pregnancy, Ann. N.Y. Acad. Sci. 114: 851–856.
Peters, M. V., 1968, The effect of pregnancy in breast cancer, in: Prognostic Factors in Breast Cancer ( A. P. M. Forrest and P. B. Kunkler, eds.), Williams and Wilkins Co., Baltimore, p. 65–80.
White, T. T. and White, W. C., 1956, Breast cancer and pregnancy: report of 39 cases followed five years, Ann. Surg. 144: 389–391.
Byrd, B. F., Jr., Bayer, D. S., Robertson, J. C., and Stephenson, S. E., Jr., 1962, Treatment of breast tumors associated with pregnancy and lactation, Ann. Surg. 155: 940–947.
Donegan, W. L., 1977, Breast cancer and pregnancy, Obstet. Gynecol. 50 (2): 244–252.
Goldsmith, H. S., 1974, Milk-rejection sign of breast cancer, Am. J. Surg. 127: 280–281.
Cheek, J. H., 1953, Survey of current opinions concerning carcinoma of the breast occuring during pregnancy, Arch. Surg. 66: 664–668.
Costarides, J. and Theofanides, C., 1963, Carcinoma of the breast during pregnancy or lactation, J. Int. Coll. Surg. 40: 146–151.
Haagensen, C. D., 1967, Cancer of the breast in pregnancy and during lactation, Am. J. Obstet. Gynecol. 98: 141–149.
Rissanen, P. M., 1968, Carcinoma of the breast during pregnancy and lactation, Br. J. Cancer. 22: 663–668.
Helman, P. and Bennett, M. B., 1963, Breast cancer and pregnancy, S. Afr. Med. J. 37: 1236–1239.
Erwald, R., 1967, Mammary carcinoma and pregnancy, Acta Obstet. Gynecol. Scand. 46: 316–326.
Potter, J. F. and Schoeneman, M., 1970, Metastases of maternal cancer to the placenta and fetus, Cancer 25: 380–388.
Cheek, J. H., 1973, Cancer of the breast in pregnancy and lactation, Am. J. Surg. 126: 729–731.
Peete, C. H., Jr., Shimkin, M. B., and Moss, N. H., 1969, Cancer of the breast in pregnancy, N. Carolina Med. J. 27: 514–520.
Earley, T. K., Gallagher, J. Q., and Chapman, K. E., 1969, Carcinoma of the breast in women under thirty years of age, Am. J. Surg. 118: 832–834.
Haagensen, C. D., 1971, Diseases of the breast, W. B. Saunders Co., Philadelphia, p. 662.
Holleb, A. I. and Farrow, J. H., 1962, The regulation of carcinoma of the breast and pregnancy in 283 patients, Surg. Gynecol. Obstet. 115: 65–71.
Rosemond, G. P., 1963, Carcinoma of the breast during pregnancy, Clin. Obstet. Gynecol. 6: 994–1001.
Bunker, M. L. and Peters, M. V., 1963, Breast cancer associated with pregnancy or lactation, Am. J. Obstet. Gynecol. 85: 312–319.
Devitt, J. E., Beattie, W. G., and Stoddart, T. G., 1964, Carcinoma of the breast and pregnancy, Can. J. Surg. 7: 124–128.
Matsumoto, K. Ochi, H., Momura, Y. Takatani, O., Izuo, M., Okamoto, R., and Sugano, H., 1978, Progesterone and estrogene receptors in Japanese breast cancer, in: Hormones, Receptors and Breast Cancer ( W. L. McGuire, ed.), Raven Press, New York, pp. 43–58.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Plenum Press, New York
About this chapter
Cite this chapter
Mockus, M.B., Horwitz, K.B. (1983). Pregnancy, Lactation, and Breast Cancer. In: Neville, M.C., Neifert, M.R. (eds) Lactation. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-3688-4_15
Download citation
DOI: https://doi.org/10.1007/978-1-4613-3688-4_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-3690-7
Online ISBN: 978-1-4613-3688-4
eBook Packages: Springer Book Archive